| Financial Year |
March 31 2023 |
| Monetary Funds |
1,262,971,823.16 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
55,086,318.94 |
| Accounts Receivable |
150,424,299.48 |
| Advances to Suppliers |
23,114,274.11 |
| Other Receivables |
2,076,622.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
205,764,004.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
65,609,097.51 |
| Total Current Assets |
1,815,046,440.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
25,085,481.34 |
| Under-construction Projects |
62,174,230.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,052,531.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
44,609,039.90 |
| Other Non-Current Assets |
43,396,836.84 |
| Sub-Total of Non-Current Assets |
358,328,263.40 |
| Total Assets |
2,173,374,703.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,438,235.15 |
| Accounts Payable |
72,829,366.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,276,239.98 |
| Taxes Payable |
3,194,720.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,625,259.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,521,921.80 |
| Other Current Liabilities |
9,107,967.96 |
| Sub-Total of Current Liabilities |
254,207,600.87 |
| Long-term Loans |
400,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
478,249,198.10 |
| Total Liabilities |
732,456,798.97 |
| Paid-In Capital(Or Share Stock) |
117,350,000.00 |
| Capital Surplus |
604,064,204.21 |
| Surplus Reserve |
64,295,699.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
626,429,101.11 |
| Minority Stockholder's Interest |
3,109,710.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,437,808,194.41 |
| Owner's Equity（Stockholder's Equity） |
1,440,917,904.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,173,374,703.66 |
